Posted on 3/29/18
Forget Merck: Novavax, Inc. Is a Better Vaccine Stock
Could Novavax, Inc. (NASDAQ:NVAX) be a better vaccine stock than Merck (NYSE:MRK)? I think so.That might sound crazy. After all, Novavax is tiny and unproven. It's . . .
Posted on 3/28/18
Actinium Pharmaceuticals Announces Collaborative Research Partnership with Astellas Leveraging Actinium’s AWE Platform Technology
NEW YORK, March 28, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN:ATNM), announced today that it has entered into a research and option agreement with . . .
Posted on 3/28/18
ImmuDyne Signs Exclusive License Agreement for Clinically-Backed Solar Purpura Product
NEW YORK, March 28, 2018 (GLOBE NEWSWIRE) -- ImmuDyne, Inc. (OTCQB:IMMD), a leader in the development and marketing of Over-the-Counter healthcare products, is pleased to announce . . .
Posted on 3/28/18
Interpace Diagnostics Announces Agreement with Acupath Laboratories
PARSIPPANY, N.J., March 28, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG), a fully integrated commercial and bioinformatics company that provides clinically useful molecular diagnostic tests . . .
Posted on 3/28/18
PTC Therapeutics Announces Proposed Public Offering of Common Stock
PTC Therapeutics, Inc. (Nasdaq: PTCT) announced today that it is commencing a public offering of 4,000,000 shares of its common stock. All of the shares in . . .
Posted on 3/27/18
Antares Pharma Provides XYOSTED Regulatory Update
EWING, N.J., March 27, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that the official minutes from the Type A meeting with the U.S. . . .
Posted on 3/27/18
Better Stock: Verizon Communications Inc. (VZ) vs. Johnson & Johnson (JNJ)
Johnson & Johnson (NYSE:JNJ) and Verizon (NYSE:VZ) have long been bastions of bountiful dividend income for investors. With the stocks of the healthcare colossus and telecom . . .
Posted on 3/27/18
Is Pfizer's Best Option Now a Consumer Healthcare Spinoff?
More doors are closing than opening for Pfizer (NYSE:PFE) with regard to the big drugmaker's options for its consumer healthcare business. Pfizer announced in October that . . .
Posted on 3/27/18
Don't Worry, Pfizer Isn't Out of Options for Its Consumer Health Division Just Yet
Last October, Pfizer (NYSE:PFE) announced that it was reviewing strategic alternatives for its consumer healthcare division that sells over-the-counter products, such as Advil and Centrum vitamins. . . .
Posted on 3/26/18
Will Philip Morris International Really Stomp Out Its Own Cigarette Business?
Tobacco use dates back for centuries, and cigarettes have been a huge business that have driven business for Philip Morris International (NYSE:PM) for decades. Yet the . . .
Posted on 3/26/18
Better Buy: Johnson & Johnson vs. Merck
The healthcare industry has many massive players, but they tend to concentrate on different areas of the market. Johnson & Johnson (NYSE:JNJ) is a true healthcare . . .
Posted on 3/26/18
Arena Pharmaceuticals Takes Aim at Celgene
On Monday, Arena Pharmaceuticals (NASDAQ:ARNA) unveiled mid-stage trial results for etrasimod, an S1P-modulating drug that works similarly to ozanimod, one of Celgene's (NASDAQ:CELG) most anticipated drugs. . . .
Posted on 3/26/18
Is Merck & Co. Inc. a Buy?
Several big pharma stocks have performed relatively well over the last 12 months. But not Merck & Co. (NYSE:MRK). The drugmaker actually claims one of the . . .
Posted on 3/26/18
Gilead Sciences' Investors Better Watch This Regeneron-Alnylam Deal
The chronic liver disease nonalcoholic steatohepatitis (NASH) is supposed to be Gilead Sciences' (NASDAQ:GILD) next hepatitis C -- a disease that doubled Gilead's sales almost overnight. . . .
Posted on 3/22/18
EpigenCare Named as Johnson & Johnson Innovation Finalist in Skincare Challenge
EpigenCare Inc., a personalized skincare startup company, has been named by Johnson & Johnson Innovation as a finalist in its Digital Beauty Quickfire Challenge. The challenge . . .
Posted on 3/21/18
Regeneron and Alnylam Pharmaceuticals Announce Collaboration
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) today announced a collaboration to identify RNAi therapeutics for the chronic liver disease nonalcoholic steatohepatitis . . .
Posted on 3/21/18
Tonix Pharmaceuticals Expands Intellectual Property Portfolio for TNX-102 SL
NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a clinical-stage biopharmaceutical company focused on developing pharmaceutical products to treat serious . . .
Posted on 3/21/18
Johnson & Johnson: Dividend Hike Ahead
Johnson & Johnson (NYSE:JNJ) has incurred a 12% correction during the last two months. Nevertheless, most of its shareholders have a long-term perspective and thus hold . . .
Posted on 3/21/18
Celgene: A High-Growth Stock Trading At A Cheap Price
Celgene (CELG) offers a good combination of value and growth at the current price. The company trades at 10.5 price to forward-looking earnings and the earnings . . .
Posted on 3/20/18
Is Pfizer's CEO Ian Read Really Worth 61% More?
A proxy filed with the Securities and Exchange Commission shows that Pfizer (NYSE:PFE) paid CEO Ian Read $27.9 million in 2017, a 61% increase over the . . .
Posted on 3/20/18
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on March 13, 2018 it approved non-statutory stock options to purchase an aggregate of 25,200 shares of its . . .
Posted on 3/18/18
Centers Health Care Announces the Winner of the 2018 Patient Advocacy Award at the Roosevelt Hotel Grand Ballroom in New York City
Centers Health Care, one of the largest and most complete post-acute health care continuums in the northeast, announced that the recipient of the 2018 Centers Health . . .
Posted on 3/16/18
Johnson & Johnson To Divest LifeScan Unit For $2.1B
Johnson & Johnson (NYSE:JNJ) announces that it has received a $2.1B binding offer from private equity shop Platinum Equity for its LIfeScan glucose monitoring business.The deadline . . .
Posted on 3/16/18
Stemline Therapeutics Reports Fourth Quarter 2017 Financial Results
NEW YORK, March 16, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today financial results for the quarter . . .
Posted on 3/16/18
How Pfizer Plans to Move Into the Big Leagues for Cancer Treatment
Pfizer (NYSE:PFE) ranks as the biggest drugmaker in the world in terms of prescription drug sales. But the company hasn't really been at the forefront in . . .

